©The Author(s) 2025.
World J Psychiatry. Dec 19, 2025; 15(12): 108867
Published online Dec 19, 2025. doi: 10.5498/wjp.v15.i12.108867
Published online Dec 19, 2025. doi: 10.5498/wjp.v15.i12.108867
Figure 5 Immunohistochemical, PCR, and Western blot results of rats in each group.
A: Immunohistochemical results; B-G: PCR detection of the mRNA expression of AANAT, SIRT1, PGC-1α, NRF1, TFAM and mtDNA in the hypothalamus; H: Western blot detection of the protein expression of AANAT, SIRT1, PGC-1α, NRF1, TFAM in the hypothalamus. aP < 0.001, model group vs control group; bP < 0.001, Sini-Suanzaoren decoction (SNSZRD) high dose group vs model group; cP < 0.001, SNSZRD middle dose group vs model group; dP < 0.01, positive group vs model group; eP < 0.01, SNSZRD middle dose group vs model group; fP < 0.05, SNSZRD low dose group vs model group; gP < 0.05, SNSZRD middle dose group vs model group.
- Citation: Li RT, Lan BJ, Xiao ZY, Shi QH, Chen XY, Li F. Sini-Suanzaoren decoction regulates mitochondrial biogenesis mediated by MT-SIRT1 in the treatment of insomnia rats. World J Psychiatry 2025; 15(12): 108867
- URL: https://www.wjgnet.com/2220-3206/full/v15/i12/108867.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i12.108867